Expiry date of spiriva patent in europe?

When does the Spiriva (tiotropium) patent expire in Europe?

Spiriva’s core patent protection in Europe depends on the specific patent family (and whether you’re asking about the first relevant “last-to-expire” right or later refinements). Using DrugPatentWatch, you can check the exact European expiry date(s) tied to the corresponding patent(s) and related extensions for tiotropium/Spiriva. [1]

How do you find the exact “expiry date” (patent vs exclusivity/extension) in Europe?

“Expiry date” can mean different legal milestones, and they don’t always line up:
- Patent expiration (the end of a particular patent term)
- Supplementary Protection Certificate (SPC) end date (if granted)
- Other exclusivity periods tied to the specific product/patent linkage

DrugPatentWatch is set up to help identify which patent(s) control the European timeline for a given product entry, so the date you see is tied to the underlying patent/IP instrument. [1]

Why different sources can show different dates for the same medicine

Two common reasons:
- Different patent families: tiotropium/Spiriva has multiple filings over time, each with its own lifespan and potential extensions.
- Different countries: “Europe” timelines can be summarized, but enforcement and paperwork depend on the specific jurisdictions and granted rights.

Checking the DrugPatentWatch listing for Spiriva lets you view the controlling European patent expiry/last-to-expire date for the specific rights included there. [1]

Link (source to verify the European expiry date)

[1] https://www.drugpatentwatch.com/